Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M256Revenue $M6.3Net Margin (%)-409.9Altman Z-Score-51.0
Enterprise Value $M287EPS $-0.2Operating Margin %-352.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.8Pre-tax Margin (%)-409.9Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.6Cash flow > EarningsY
Price/Sales33.45-y EBITDA Growth Rate %31.1Current Ratio0.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-161.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M151ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

NAVB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-06-01Sell12,500$1.2437.1 view
Troup Gordon ADirector 2015-05-29Buy10,000$1.3129.77 view
FORD BRENDAN ADirector 2015-05-21Buy20,000$1.3129.77 view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-05-01Sell12,500$1.3327.82 view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-04-01Sell20,000$1.587.59 view
GOLDBERG MICHAEL MDirector 2014-11-14Buy100,000$1.0857.41 view
FORD BRENDAN ADirector 2014-11-10Buy10,000$1.0365.05 view
Nordlicht Mark10% Owner 2014-09-02Sell60,000$1.3625 view
Regan William J.SVP-Global Reg Affairs&Quality 2014-05-12Buy5,000$1.4318.88 view
PYKETT MARK JEROMECEO 2014-05-09Buy10,000$1.3426.87 view

Quarterly/Annual Reports about NAVB:

News about NAVB:

Articles On GuruFocus.com
Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 
comment on NAVB Mar 15 2013 

More From Other Websites
Navidea reports 2Q loss Jul 30 2015
Navidea reports 2Q loss Jul 30 2015
Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek® Revenue Guidance Jul 30 2015
Navidea Biopharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Jul 30 2015
7:38 am Navidea Biopharma misses by $0.02, beats on revs Jul 30 2015
Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek® Revenue Guidance Jul 30 2015
Q2 2015 Navidea Biopharmaceuticals Inc Earnings Release - Time Not Supplied Jul 30 2015
Navidea Awarded $1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept™ in Rheumatoid... Jul 29 2015
Navidea Awarded $1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept™ in Rheumatoid... Jul 29 2015
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Jul 28 2015
Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular... Jul 28 2015
Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular... Jul 28 2015
Verification of Lymphoseek® Mechanism of Action Published in Journal of Immunology Jul 23 2015
Verification of Lymphoseek® Mechanism of Action Published in Journal of Immunology Jul 23 2015
Navidea Biopharmaceuticals to Announce Second Quarter 2015 Financial Results on July 30, 2015 Jul 22 2015
Navidea Biopharmaceuticals to Announce Second Quarter 2015 Financial Results on July 30, 2015 Jul 22 2015
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Jul 21 2015
Navidea Biopharmaceuticals Announces 2015 Annual Meeting Results Jul 16 2015
Navidea Biopharmaceuticals Announces 2015 Annual Meeting Results Jul 16 2015
Partnerships Rather Than Buyouts May Become Big Pharma's Choice In Collaborating With Biotechs Jul 12 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK